IMRX
Price
$5.30
Change
+$0.05 (+0.95%)
Updated
Aug 21 closing price
Capitalization
342.9M
74 days until earnings call
Intraday BUY SELL Signals
SION
Price
$5.29
Change
-$0.23 (-4.17%)
Updated
Aug 21 closing price
Capitalization
239.17M
80 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMRX vs SION

IMRX vs SION Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMRX vs. SION commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMRX is a Hold and SION is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 23, 2026
Stock price -- (IMRX: $5.30 vs. SION: $5.29)
Brand notoriety: IMRX and SION are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMRX: 37% vs. SION: 94%
Market capitalization -- IMRX: $342.9M vs. SION: $239.17M
IMRX [@Biotechnology] is valued at $342.9M. SION’s [@Biotechnology] market capitalization is $239.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $138.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMRX’s FA Score shows that 0 FA rating(s) are green whileSION’s FA Score has 1 green FA rating(s).

  • IMRX’s FA Score: 0 green, 5 red.
  • SION’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMRX and SION are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMRX’s TA Score shows that 5 TA indicator(s) are bullish while SION’s TA Score has 5 bullish TA indicator(s).

  • IMRX’s TA Score: 5 bullish, 5 bearish.
  • SION’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both IMRX and SION are a good buy in the short-term.

Price Growth

IMRX (@Biotechnology) experienced а +4.74% price change this week, while SION (@Biotechnology) price change was -18.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +15.94%, and the average quarterly price growth was +3349.70%.

Reported Earning Dates

IMRX is expected to report earnings on Nov 05, 2026.

SION is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMRX($343M) has a higher market cap than SION($239M). IMRX YTD gains are higher at: -19.453 vs. SION (-87.141). IMRX has higher annual earnings (EBITDA): -63.82M vs. SION (-98.28M). SION has more cash in the bank: 216M vs. IMRX (157M). IMRX has less debt than SION: IMRX (3.73M) vs SION (8.38M). IMRX (0) and SION (0) have equivalent revenues.
IMRXSIONIMRX / SION
Capitalization343M239M144%
EBITDA-63.82M-98.28M65%
Gain YTD-19.453-87.14122%
P/E RatioN/AN/A-
Revenue00-
Total Cash157M216M73%
Total Debt3.73M8.38M45%
TECHNICAL ANALYSIS
Technical Analysis
IMRXSION
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 5 days ago
88%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
Bearish Trend 3 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMRX
Daily Signal:
Gain/Loss:
SION
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VKSCX17.630.17
+0.97%
Virtus KAR Small-Mid Cap Core C
LGRCX23.740.22
+0.94%
Loomis Sayles Growth C
TRNEX50.250.44
+0.88%
T. Rowe Price New Era I
SAUMX38.170.26
+0.69%
SA US Small Company
GIUIX43.310.13
+0.30%
NAA Mid Growth Institutional

IMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMRX has been loosely correlated with SPRB. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMRX jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMRX
1D Price
Change %
IMRX100%
+0.95%
SPRB - IMRX
52%
Loosely correlated
-0.78%
CRMD - IMRX
40%
Loosely correlated
-0.36%
ACRV - IMRX
36%
Loosely correlated
+0.45%
SION - IMRX
35%
Loosely correlated
-4.17%
JSPR - IMRX
34%
Loosely correlated
+3.59%
More

SION and

Correlation & Price change

A.I.dvisor indicates that over the last year, SION has been closely correlated with TENX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if SION jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SION
1D Price
Change %
SION100%
-4.17%
TENX - SION
93%
Closely correlated
-1.69%
HRTX - SION
44%
Loosely correlated
+2.98%
PLRX - SION
43%
Loosely correlated
+3.12%
MGTX - SION
42%
Loosely correlated
-1.38%
BCAX - SION
40%
Loosely correlated
-2.01%
More